These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9307185)

  • 1. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
    Piao Z; Kim H; Jeon BK; Lee WJ; Park C
    Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
    Shao J; Li X; Liu Z
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on loss of heterozygosity and microsatellite instability in hepatocellular carcinoma].
    Cong WM; Zhang SH; Xian ZH; Wu WQ; Wu MC
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):71-4. PubMed ID: 15842799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
    Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
    Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of cell cycle-related genes in hepatocarcinogenesis.
    Nishida N; Fukuda Y; Ishizaki K; Nakao K
    Histol Histopathol; 1997 Oct; 12(4):1019-25. PubMed ID: 9302564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Features of micro satellite alterations on chromosome 4 in hepatocellular carcinoma].
    Zhang SH; Cong WM; Xian ZH; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):223-6. PubMed ID: 15099473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
    Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
    Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1252-60. PubMed ID: 7868063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
    Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A
    Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
    Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
    Ai Zheng; 2003 Jul; 22(7):680-5. PubMed ID: 12866955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutation spectrum in hepatocellular carcinoma.
    Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
    Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
    Li X; Ding M; Lai B
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
    Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
    J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.